351 related articles for article (PubMed ID: 21195075)
1. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans.
Ruiz-Lancheros E; Viau C; Walter TN; Francis A; Geary TG
Int J Parasitol; 2011 Mar; 41(3-4):455-61. PubMed ID: 21195075
[TBL] [Abstract][Full Text] [Related]
2. Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle.
Robertson AP; Clark CL; Burns TA; Thompson DP; Geary TG; Trailovic SM; Martin RJ
J Pharmacol Exp Ther; 2002 Sep; 302(3):853-60. PubMed ID: 12183640
[TBL] [Abstract][Full Text] [Related]
3. A new class of anthelmintics effective against drug-resistant nematodes.
Kaminsky R; Ducray P; Jung M; Clover R; Rufener L; Bouvier J; Weber SS; Wenger A; Wieland-Berghausen S; Goebel T; Gauvry N; Pautrat F; Skripsky T; Froelich O; Komoin-Oka C; Westlund B; Sluder A; Mäser P
Nature; 2008 Mar; 452(7184):176-80. PubMed ID: 18337814
[TBL] [Abstract][Full Text] [Related]
4. Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris.
Martin RJ; Clark CL; Trailovic SM; Robertson AP
Int J Parasitol; 2004 Aug; 34(9):1083-90. PubMed ID: 15313135
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
[TBL] [Abstract][Full Text] [Related]
6. Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle.
Rayes D; Flamini M; Hernando G; Bouzat C
Mol Pharmacol; 2007 May; 71(5):1407-15. PubMed ID: 17314321
[TBL] [Abstract][Full Text] [Related]
7. Activation of
Turani O; Hernando G; Corradi J; Bouzat C
Mol Pharmacol; 2018 Nov; 94(5):1270-1279. PubMed ID: 30190363
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic acetylcholine receptors: a comparison of the nAChRs of Caenorhabditis elegans and parasitic nematodes.
Holden-Dye L; Joyner M; O'Connor V; Walker RJ
Parasitol Int; 2013 Dec; 62(6):606-15. PubMed ID: 23500392
[TBL] [Abstract][Full Text] [Related]
9. Methyridine (2-[2-methoxyethyl]-pyridine]) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisole-resistance.
Martin RJ; Bai G; Clark CL; Robertson AP
Br J Pharmacol; 2003 Nov; 140(6):1068-76. PubMed ID: 14581174
[TBL] [Abstract][Full Text] [Related]
10. Tribendimidine: mode of action and nAChR subtype selectivity in Ascaris and Oesophagostomum.
Robertson AP; Puttachary S; Buxton SK; Martin RJ
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003495. PubMed ID: 25679515
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of pyrantel selectivity in nicotinic receptors.
Bartos M; Rayes D; Bouzat C
Mol Pharmacol; 2006 Oct; 70(4):1307-18. PubMed ID: 16825485
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans.
Gottschalk A; Almedom RB; Schedletzky T; Anderson SD; Yates JR; Schafer WR
EMBO J; 2005 Jul; 24(14):2566-78. PubMed ID: 15990870
[TBL] [Abstract][Full Text] [Related]
13. Monepantel allosterically activates DEG-3/DES-2 channels of the gastrointestinal nematode Haemonchus contortus.
Rufener L; Baur R; Kaminsky R; Mäser P; Sigel E
Mol Pharmacol; 2010 Nov; 78(5):895-902. PubMed ID: 20679419
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57.
Martin RJ; Robertson AP
Parasitology; 2007; 134(Pt 8):1093-104. PubMed ID: 17608969
[TBL] [Abstract][Full Text] [Related]
15. Functional genomics in
Verma S; Kashyap SS; Robertson AP; Martin RJ
Proc Natl Acad Sci U S A; 2017 May; 114(21):5539-5544. PubMed ID: 28487481
[TBL] [Abstract][Full Text] [Related]
16. Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study.
Weaver KJ; May CJ; Ellis BL
PLoS One; 2017; 12(6):e0179376. PubMed ID: 28632749
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum.
Qian H; Martin RJ; Robertson AP
FASEB J; 2006 Dec; 20(14):2606-8. PubMed ID: 17056760
[TBL] [Abstract][Full Text] [Related]
18. Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle.
Atchison WD; Geary TG; Manning B; VandeWaa EA; Thompson DP
Toxicol Appl Pharmacol; 1992 Jan; 112(1):133-43. PubMed ID: 1310165
[TBL] [Abstract][Full Text] [Related]
19. Contributions from Caenorhabditis elegans functional genetics to antiparasitic drug target identification and validation: nicotinic acetylcholine receptors, a case study.
Brown LA; Jones AK; Buckingham SD; Mee CJ; Sattelle DB
Int J Parasitol; 2006 May; 36(6):617-24. PubMed ID: 16620825
[TBL] [Abstract][Full Text] [Related]
20. Discovery of amino-acetonitrile derivatives, a new class of synthetic anthelmintic compounds.
Ducray P; Gauvry N; Pautrat F; Goebel T; Fruechtel J; Desaules Y; Weber SS; Bouvier J; Wagner T; Froelich O; Kaminsky R
Bioorg Med Chem Lett; 2008 May; 18(9):2935-8. PubMed ID: 18400497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
